IS INTERMITTENT DOCETAXEL CHEMOTHERAPY REASONABLE IN HORMONE REFRACTORY PROSTATE CANCER? A PILOT RANDOMIZED STUDY


Akdogan B., Yazici S. , Kirdal Y., Inci K., Erman M., Ozen H.

104th Annual Meeting of the American-Urological-Association, Illinois, United States Of America, 25 - 30 April 2009, vol.181, pp.233 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 181
  • Doi Number: 10.1016/s0022-5347(09)60663-7
  • City: Illinois
  • Country: United States Of America
  • Page Numbers: pp.233